A very special first post on Bluesky: Iβm excited to share that Iβll be starting my lab at Penn State this coming January in the Dept of Biochemistry & Molecular Biology! Iβll be hiring at all levels soon. Check out updates, thoughts, and positions on the lab account: @hanna-lab.bsky.social
28.05.2025 13:25 β π 103 π 14 π¬ 14 π 0
Opinion | Science Suffers With Trumpβs Funding Freeze
Americaβs scientific enterprise demands reliable stewardship, not destabilizing political intervention.
My father-in-law, Jack Strominger, and I wrote a letter to the @wsj.com editor about the current threats to science due to Trump's funding freeze. Please repost! www.wsj.com/opinion/scie...
21.04.2025 18:21 β π 180 π 142 π¬ 2 π 7
What a delightful visit to Penn State, hosted by @cdokafor.bsky.social! π We cooked up a new collab, had a fun new PI dinner with @erdavenport.bsky.social, AND I managed to reclaim some joy by talking chromatin & mentoring with the great folks in BMB. (Forever grateful for our Emory IRACDA fam!)
15.04.2025 02:23 β π 6 π 1 π¬ 0 π 0
Today is the 5th anniversary of the lab! Thankful for the home I've found at Penn State and the people I've found it with. Happy new year!
02.01.2025 17:17 β π 2 π 0 π¬ 0 π 0
we extended our simulations to the full length heterodimer complex between FXR and RXR (retinoid X receptor alpha). We revealed a variety of underappreciated roles for the FXR hinge in the context of the dimer, including in DNA binding, interdomain allostery and dimer flexibility
23.12.2024 18:50 β π 1 π 0 π¬ 0 π 0
https://pubs.acs.org/doi/10.1021/acsbiomedchemau.4c00105
6. Simulations Reveal Unique Roles for the FXR Hinge in the FXRβRXR Nuclear Receptor Heterodimer (Nov 2024) in the 2024 Rising Stars in Biological, Medicinal, and Pharmaceutical Chemistry edition of ACS Bio & Med Chem Au.
t.co/vj7z16cePG
23.12.2024 18:50 β π 1 π 0 π¬ 1 π 0
In this work, we used simulations and experiments on full length farnesoid X receptor (FXR) to show for the first time that ligands selectively mediate contact betwen the DNA and ligand binding domains. We showed that the interdomain hinge plays an active role in this process
23.12.2024 18:50 β π 0 π 0 π¬ 1 π 0
https://www.sciencedirect.com/science/article/pii/S0022283624004273?via%3Dihub
5. Nuclear Receptor Interdomain Communication is Mediated by the Hinge with Ligand Specificity (Nov 2024) in J. Mol. Biol.
t.co/UMfRvr1bBG
23.12.2024 18:50 β π 0 π 0 π¬ 1 π 0
In this work, we performed extensive analysis on 27 nuclear receptor complexes, aimed at learning how simulation lengths and number of replicas affect results obtained from MD studies. This work provides a benchmark for researchers studying similar research questions/size systems
23.12.2024 18:50 β π 0 π 0 π¬ 1 π 0
https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cphc.202400783
4. Impact of Replicas and Simulation Length on In Silico Behaviors of a Protein Domain (October 2024) in ChemPhysChem as part of the Physical Chemistry Talents collection.
t.co/m6qGO4vPEO
23.12.2024 18:50 β π 0 π 0 π¬ 1 π 0
We used MD simulations to show that PR evolved a distinct mechanism of activation from other steroid hormone receptors. However it maintains vestiges of this ancient mechanism, allowing it to be weakly activated by certain hydroxylated steroidal ligands.
23.12.2024 18:50 β π 0 π 0 π¬ 1 π 0
https://sciencedirect.com/science/article/pii/S187493992400021X?via%3Dihub
3. Illuminating ligand-induced dynamics in nuclear receptors through MD simulations (June 2024) - a review article published in Biochim Biophys Acta Gene Regul Mech.
t.co/IVSXwVtUog
23.12.2024 18:50 β π 0 π 0 π¬ 1 π 0
We used MD simulations to show that PR evolved a distinct mechanism of activation from other steroid hormone receptors. However it maintains vestiges of this ancient mechanism, allowing it to be weakly activated by certain hydroxylated steroidal ligands. #rscchembio
23.12.2024 18:50 β π 0 π 0 π¬ 1 π 0
https://pubs.rsc.org/en/content/articlelanding/2024/cb/d4cb00002a
2. Ancient and modern mechanisms compete in progesterone receptor activation (Feb 2024). published in
RSC Chem. Bio. as part of the 2023 RSC Chemical Biology Emerging Investigators themed edition.
t.co/zQNbH95whN
23.12.2024 18:50 β π 0 π 0 π¬ 1 π 0
We study the transition betweeen active and inactive conformations of the PR ligand binding domain. We show that active and inactive states represent global and local minima respectively, the transition between them is ligand modulated, and occurs on millisecpmd timescales. #jcp
23.12.2024 18:50 β π 0 π 0 π¬ 1 π 0
https://pubs.aip.org/aip/jcp/article-abstract/160/11/115102/3277836/How-nuclear-rrseceptors-transition-between-active?redirectedFrom=fulltext
1. How nuclear receptors transition between active and inactive forms: An energetic perspective (Jan 2024). Published in J. Chem Phys as part of the 2024 JCP Emerging Investigators Special Collection
t.co/4dEiD6vNKs
23.12.2024 18:50 β π 1 π 0 π¬ 1 π 0
we study the origin of potency in agonists of the farnesoid X receptor. We show that bile acids induce dynamic coupling between helices 5 and 7 of the ligand binding domain. A modification on the bile acid scaffold further strengthens this coupling, explaining its higher efficacy
23.12.2024 18:50 β π 0 π 0 π¬ 1 π 0
https://www.jbc.org/article/S0021-9258(24)02583-3/fulltext
7. Enhanced dynamic coupling in a nuclear receptor underlies ligand activity
t.co/CJmX1WQToW
23.12.2024 18:50 β π 0 π 0 π¬ 1 π 0
I am excited to share our work in
J. Mol. Biol. which is our 7th publication on #nuclearreceptors for the 2024 calendar year! Please read on for a summary of all 7 publications from our lab this year, as well as links to the papers.
23.12.2024 18:50 β π 5 π 1 π¬ 1 π 0
Postdoctoral Research Associate at St Jude Childrenβs Research Hospital | RNA Biologist
Asst. Professor of Biological Chemistry & Pharmacology, Center for RNA Biology, The Ohio State University; we study ribosomes & mRNA translation in human biology & disease; advocate for equity & diversity; www.kearselab.org
The McCully Lab at Santa Clara University studies the structure, dynamics, and function of proteins towards designing better ones.
sites.google.com/site/mccullylabscu
BS WashU | PhD UW | Postdoc UCSF | Assoc prof SCU
Acamama, PUI, family biking, Bay Area
Scientist. Christ-follower. Prof @UPenn. Director of Folding@home. Legaly blind. Father.
Organic chemist with a weird accent from New Jersey
Clinical academic endocrinologist and circadian metabolism researcher at the University of Manchester, UK. Clocks and genomics are cool. That and other views mine. She/her.
Studying the complexity of the brain to cure diseases. Genomics aficionado. Academic mom of 2. First generation college student. Lover of the outdoor life and espresso. https://www.teleselab.com
LMU Munich
Chemical Biology of Protein Post-Translational Modifications
Chemoproteomics, Click Chemistry, Mass Spectrometry
Chemist, Dad, Group Leader, Associate Professor. Excited about novel chemical modalities in drug discovery
Professor at Aarhus University. Total synthesis of natural products. Covalent chemical biology.
Co-founder: Mmimetika Biosciences and Kripthonite Therapeutics
nucleic acids, polymerases, helicases, and mitochondria at Tufts University
Ms Organic Chemistry Student
Computational Biophysicist, Amateur Photographer, History+Language Nerd.
All views my own.
Website: https://martinvoegele.github.io/
RNA and DNA geek | Structure-function of nucleic acids | Assistant Professor at the University of Florida | My views. Website: https://sites.google.com/view/passalacqualab/
Medicinal Chemist. Views expressed are my own.
PhD student in the Lang group at ETH Zurich π¦ π§¬π§ͺπ¬
Professor of Chemistry at University of Southern California; https://www.theprattlab.com; glycoscience, protein aggregation, neurodegeneration
radical biocatalysis π€ artificial metalloenzymes
π·πΈ PhD student @RoelfesGroup.bsky.social
University of Groningen π³π±